Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors
- PMID: 17725323
- DOI: 10.1021/bi7006542
Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors
Abstract
Diketoacid (DKA) compounds have been shown to inhibit HIV-1 integrase by a mechanism that involves sequestration of the active site metals. Because HIV-1 integrase and Tn5 transposase have similar active site architectures and catalytic mechanisms, we investigated whether DKA analogues would inhibit Tn5 transposase activity and provide a model system to explore the mechanisms of action of these inhibitors. A screen of several hundred DKA analogues identified several with activity against Tn5 Tnp. Six DKA inhibitors used in this study manifested a variety of effects on different transposition steps suggesting that different analogues may have different binding contacts with transposase. All DKA compounds inhibited paired end complex (PEC) formation in which the nucleoprotein complex required for catalysis is assembled. Dissociation of PECs by some DKA compounds indicates that these inhibitors can decrease PEC stability. Four DKA compounds inhibited the two cleavage steps releasing transposon DNA from flanking DNA, and one of these four compounds preferentially inhibited the second cleavage step. The differential effect of this inhibitor on the second cleavage event indicates that cleavage of the two transposon-donor DNA boundaries is a sequential process requiring a conformational change. The requirement for a conformational change between cleavage events was also demonstrated by the inability of transposase to perform second cleavage at 25 degrees C. Finally, all six compounds inhibit strand transfer, the final step of Tn5 transposition. Two of the compounds that inhibited strand transfer have no effect on DNA cleavage. The strand transfer inhibition properties of various DKA compounds was sensitive to the structure of the 5'-non-transferred strand, suggesting that these compounds bind in or near the transposase active site. Other results that probe compound binding sites include the effects of active site mutations and donor DNA on DKA compound inhibition activities. Thus, DKA inhibitors will provide an important set of tools to investigate the mechanism of action of transposases and integrases.
Similar articles
-
Tn5 transposase as a useful platform to simulate HIV-1 integrase inhibitor binding mode.Biochem Biophys Res Commun. 2007 Nov 23;363(3):554-60. doi: 10.1016/j.bbrc.2007.08.199. Epub 2007 Sep 14. Biochem Biophys Res Commun. 2007. PMID: 17889829
-
Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors.J Mol Biol. 2008 Jul 11;380(3):504-19. doi: 10.1016/j.jmb.2008.04.054. Epub 2008 May 1. J Mol Biol. 2008. PMID: 18565342
-
Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.Bioorg Med Chem Lett. 2006 Jun 1;16(11):2920-4. doi: 10.1016/j.bmcl.2006.03.010. Epub 2006 Mar 20. Bioorg Med Chem Lett. 2006. PMID: 16546383
-
Structure/function insights into Tn5 transposition.Curr Opin Struct Biol. 2004 Feb;14(1):50-7. doi: 10.1016/j.sbi.2004.01.008. Curr Opin Struct Biol. 2004. PMID: 15102449 Review.
-
Comparative architecture of transposase and integrase complexes.Nat Struct Biol. 2001 May;8(5):302-7. doi: 10.1038/86166. Nat Struct Biol. 2001. PMID: 11774877 Review.
Cited by
-
Crystal structures of catalytic core domain of BIV integrase: implications for the interaction between integrase and target DNA.Protein Cell. 2010 Apr;1(4):363-370. doi: 10.1007/s13238-010-0047-5. Epub 2010 May 8. Protein Cell. 2010. PMID: 21203948 Free PMC article.
-
HIV‑1 integrase inhibitors targeting various DDE transposases: Retroviral integration versus RAG‑mediated recombination (Review).Mol Med Rep. 2019 Dec;20(6):4749-4762. doi: 10.3892/mmr.2019.10777. Epub 2019 Oct 30. Mol Med Rep. 2019. PMID: 31702817 Free PMC article. Review.
-
Structural basis of Mos1 transposase inhibition by the anti-retroviral drug Raltegravir.ACS Chem Biol. 2014 Mar 21;9(3):743-51. doi: 10.1021/cb400791u. Epub 2014 Jan 10. ACS Chem Biol. 2014. PMID: 24397848 Free PMC article.
-
Inhibitors of strand transfer that prevent integration and inhibit human T-cell leukemia virus type 1 early replication.Antimicrob Agents Chemother. 2008 Oct;52(10):3532-41. doi: 10.1128/AAC.01361-07. Epub 2008 Mar 3. Antimicrob Agents Chemother. 2008. PMID: 18316517 Free PMC article.
-
Phosphate coordination and movement of DNA in the Tn5 synaptic complex: role of the (R)YREK motif.Nucleic Acids Res. 2008 Oct;36(18):5855-62. doi: 10.1093/nar/gkn577. Epub 2008 Sep 12. Nucleic Acids Res. 2008. PMID: 18790806 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources